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Abstract 
Background: We studied the association between iron intake and polymorphisms in the 
iron transporter gene, SLC40A1, and the risk of tuberculosis.  
Methods: We compared iron intake, the frequency of SLC40A1 mutations, and 
interactions between these variables among 98 TB patients and 125 controls in 
Kwazulu-Natal, South Africa.  
Results: Four SLC40A1 SNPs were associated with an increased risk of tuberculosis 
and one with reduced risk. We also found a gene-environment interaction for four non-
exonic SNPs and iron intake.  
Conclusions: This pilot study demonstrated an association between polymorphisms in 
SLC40A1 and tuberculosis and provided evidence for an interaction between dietary iron 
and SLC40A1. 
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One-third of the world’s population is infected with Mycobacterium tuberculosis (MTB), 
but only a minority of these develop active tuberculosis. Excess iron has been implicated 
as a risk factor for TB in both in vitro and clinical studies. Restriction of iron in culture 
media curtails growth of MTB, and iron loading in mice enhances bacterial growth in lung 
and spleen [2]. Iron supplementation has been shown to lead to increased morbidity and 
mortality in patients while autopsies show that death from TB can be accompanied by 
splenic iron overload [3]. Recognizing the physiological importance of iron availability for 
mycobacterial growth [4], we hypothesized that functional variants of the iron transporter, 
ferroportin 1 (FPN1), may affect host susceptibility to TB.  
 
“African iron overload syndrome” is characterized by increased iron and serum ferritin, 
but unlike “classic” HFE hemochromatosis, excess iron is localized in the reticulo-
endothelial system. Although this syndrome had been ascribed to intake of traditional 
African beer brewed in non-galvanized steel drums, an autosomal dominant form of iron 
overload has been described in which iron accumulation is restricted to 
reticuloendothelial cells [6]; this entity is now believed to be identical to the “ferroportin 
disease” associated with polymorphisms in SCL40A1, the gene which encodes the iron 
exporter, FPN1 [5].  
 
FPN1 is found on the basolateral surface of enterocytes and macrophage cell wall. The 
current model posits that dietary iron absorbed by enterocytes is moved into the 
circulation by FPN1, then circulates bound to transferrin and is delivered to tissues via 
endocytosis of the iron/transferrin complex. Most of the body’s iron is used for 
hemoglobin production by erythrocytes, and iron from senescent red blood cells is 
recovered when macrophages ingest and catabolize these cells. Macrophages transport 
scavenged iron to bone marrow, where it is released via FPN1. Gain-of-function   5 
mutations in SCL40A1 prevent FPN-1 inactivation by the iron regulatory hormone 
hepcidin, and cause a classic hemochromatosis phenotype manifested by low 
macrophage iron, increased transferrin saturation, and hepatocellular iron loading [6]. 
Loss-of-function variants inhibit the protein from localizing to the cell surface, impairing 
iron egress and leading to macrophage iron overload [7].  
 
To test the hypothesis that high levels of macrophage iron increase TB risk, we 
evaluated the gene-environment interactions between SLC40A1 polymorphisms and 
dietary iron intake and outcome, TB disease. 
 
Methods 
We conducted this study in Pietermaritzburg in KwaZulu-Natal, South Africa, an area 
inhabited by the Zulu, a group at high risk for African iron overload syndrome [8, 27]. TB 
incidence in this community is high at 1,163 per 100,000 compared to overall South 
Africa incidence of 820 per 100,000 [28]. We enrolled consecutive HIV negative patients 
over 18 years old in whom pulmonary tuberculosis was confirmed by two consecutive 
sputum smears positive for acid fast bacilli. Controls were recruited from those who 
tested HIV negative at Voluntary Counseling and Testing centers and from households 
of cases. Controls were unrelated to cases, were >18 years old, and had no history or 
symptoms of TB disease. Covariates included gender, age, race, current smoking status, 
self-reported diabetes mellitus, current alcohol use, BCG vaccination and socio-
economic status. To assess excess iron intake, we evaluated ingestion of home-brewed 
beer and vitamins. Host DNA was obtained from a saliva sample using the 
Oragene®DNA sample collection kit (DNA GenotekInc, Kanata, ON, Canada) and was 
stored at -70°C. 
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The study was approved by the institutional review board of Harvard School of Public 
Health, the Biomedical Research Ethics Committee at the University of KwaZulu-Natal, 
Durban, and the Department of Health, KwaZulu-Natal, South Africa.  
 
Sequencing of SLC40A1 
To detect new polymorphisms specific to this population, we sequenced the flanking 5’ 
and 3’ regions, promoter regions, exons, and proximal non-coding regions of the 
SLC40A1 gene from 28 cases and 18 controls. The primer design used Beckman 
Coulter Genomics’ Linux-based amplicon design software. Genomic DNA was amplified 
using Thermo-StartReddyMix PCR Master Mix (ThermoScientific) and 0.2 uM forward 
and reverse PCR primers. Solid phase reversible immobilization chemistry (AMPure - 
Beckman Coulter Genomics) and dye-terminator fluorescent sequencing were used to 
purify the PCR products. Polymorphisms were detected using polyphred 5.04 (University 
of Washington). 
 
Genotyping  
We identified thirteen SNPs in the SLC40A1 locus from the International HapMapProject 
dbSNP and selected 20 of the 41 polymorphisms identified by resequencing, choosing 
SNPs based on allele frequency  > 2%, location in the coding regions, and SNP assay 
design parameters. SNP genotyping was performed using Sequenom MALDI-TOF 
primer extension assay using the Sequenom (San Diego, CA) MassARRAY system.  
 
Statistical Analysis 
Univariate analysis was conducted using logistic regression models in STATA version 
10 . SNPs were excluded from the analysis if 1) they deviated from Hardy Weinberg 
equilibrium (P<0.001), 2) ≥25% of the data was missing, or 3) they had a pairwise   7 
threshold of r
2≥0.8 using linkage disequilibrium based pruning (PLINK 2007). Genotypes 
were coded using an allelic model, and allele frequency distributions were compared 
between cases and controls using PLINK. Gene-environment interactions with iron 
ingestion were assessed using the likelihood-ratio test (LRT) and a case-only analysis 
for a gene-environment interaction [8]. We considered results significant at the alpha 
=.05 level. 
 
 
Results 
Population 
We identified 104 persons with TB and 127 controls, of whom 100 cases and 126 
controls agreed to participate in the study. DNA samples were available from 98 cases 
and 125 controls.   
 
Host characteristics 
We found no association between iron ingestion through home-brewed beer, iron 
supplements, or multivitamins and TB disease. Factors found to be significantly 
associated with TB included age (p<.001), male sex (p=.03), and self-reported diabetes 
mellitus(p=.01).  
 
Sequencing and genotyping  
Resequencing identified 41 polymorphisms including 14 novel polymorphisms of which 
33 were genotyped and 32 had a genotyping efficiency of >75%.  
 
SNP association analyses   8 
We excluded one SNP which deviated from Hardy-Weinberg equilibrium and seven  
based on the linkage disequilibrium based pruning procedure. Table 2 shows that 
among the remaining 24 SNPs, four significantly increased the risk of TB disease 
(GRCh37190445284 P=0.01, 190445194 P=0.05, 190444943 P=0.05, 190423785 
P=0.04, while one reduced risk (190442893 P=0.03).  Three of these SNPs 
(GRCh37190445284, 190445194 and 190444943) occurred at low frequency while two 
(190423785 and 190442893) occurred in at least 25% of the population. 
 
Gene-environment interactions 
We found a significant gene-environment interaction between each of fours SNPs and 
iron intake (GRCh37 190452872 LRT P=0.02, 190446541 LRT P=.004, 190432613 LRT 
P=0.02, 190423785 LRT P=0.05; Table 3). Among persons who consumed excess iron, 
two SNPs were associated with a statistically significant increased risk of TB disease, 
GRCh37 190446541, OR 3.33 (95% CI, 1.31, 8.48) and GRCh37 190423785, OR 3.19 
(95% CI, 1.18, 8.61) and a third GRCh37 190452872 manifested an association that was 
not significant. Among those not exposed to increased iron, GRCh37 190432613 
protected against TB disease (OR 0.51 (95% CI, 0.30, 0.87). Three polymorphisms that 
were excluded by linkage disequilibrium based pruning, were closely associated with 
polymorphisms with evidence of gene-environment interactions: GRCh37 190452957 
with GRCh37 190452872; and GRCh37 190428248 and 190425474 with GRCh37 
190432613. 
 
Of note, although GRCh37 190430096, causing the amino acid substitution Q248H, was 
not found to be associated with TB disease, the OR among participants with iron 
exposure was 0.13 (95% CI, 0.01, 2.49) compared to 1.15 (95% CI, 0.55, 2.41) in those 
without.    9 
 
Discussion 
Multiple lines of evidence suggest that host iron status influences both the occurrence 
and outcomes of tuberculosis. Here, we assessed the association between 
polymorphisms in the gene SLC40A1 and active TB and found an association between 
TB disease and five polymorphisms within the iron transporter gene associated locus. 
Furthermore, we found preliminary evidence that iron ingestion through home-brewed 
beer and vitamin supplements modified the association between TB and four 
polymorphisms. These data suggest that iron metabolism defects may affect TB 
susceptibility and raise the possibility of a gene-environment interaction between 
SLC40A1 and iron intake in modifying the risk of TB.  
 
Mutations in SLC40A1 could affect MTB growth and replication through multiple routes. 
Some SLC40A1 SNPs alter the efficacy of FPN1 in absorbing iron across the duodenum 
and in iron export from macrophages [5], changes which may affect mycobacterial iron 
availability. SLC40A1 mutants also manifest altered levels of pro-inflammatory cytokines 
including tumor necrosis factor-α and macrophage migration inhibitory factor [9] and 
FPN1 over-expression has been shown to impair nitric oxide production in MTB infected 
macrophages [10].  
 
In this study, we identified SNPs associated with TB disease in the promoter, 
untranslated, intronic and downstream regions of SLC40A1. Transcriptional and 
translational control of SLC40A1 expression is thought to be tightly regulated by iron, 
and polymorphisms in non-exonic regions of SLC40A1 may alter such regulation (11). 
For example, Marro reported that heme upregulates SLC40A1 transcription and that this 
activation relies on a highly conserved enhancer region in the promoter [12]. Deletion of   10 
the iron responsive element (IRE) in the 5’ UTR region abrogated this effect, suggesting 
that the IRE confers translational regulation through iron regulatory proteins that bind to 
the mRNA transcript in low iron states to prevent translation. Alternative promoters and 
splicing have also led to the loss of an IRE in SLC40A1 transcripts in vivo [13]. Notably, 
two of the polymorphisms that we found to be associated with TB disease are located in 
the 5’UTR in proximity to the IRE, raising the possibilities that polymorphisms in the 
promoter regions may alter transcriptional regulation while those in the untranslated 
regions may affect the function of the IRE and therefore translational regulation. 
 
 Iron ingestion modified the association between TB disease and four SNPs found near 
the promoter, and in intronic and untranslated regions. This interaction may have 
resulted from altered iron absorption at the level of the duodenum or impaired iron 
egress from macrophages in the setting of excess iron intake. Polymorphisms affecting 
transcription may render SLC40A1 unresponsive to iron regulation through the IRE, 
which may also lead to macrophage iron overload. We note that the mutation, Q248H 
has been previously associated with an iron metabolism phenotype in African and 
African Americans and that affected carriers exhibit elevated ferritin levels, reduced 
mean corpuscular volumes, elevated C-reactive protein levels, and low levels of tumor 
necrosis factor and macrophage inhibitory factor [14]. In vitro experiments show that 
Q248H mutants retain their ability to export iron, and some investigators have 
speculated that the mutation may produce a variant of FPN1 that is not inhibited by 
hepcidin and thus functions as a “permanently turned-on iron exporter” [15]. Our finding 
that Q248H was protective against TB disease among those with increased iron intake, 
although not statistically significant, is consistent with this phenotype, since carriers 
would be expected to have low macrophage iron levels even in the presence of excess 
circulating iron.     11 
 
This study had multiple limitations. Although we attempted to capture relevant SNPs, we 
did not sequence the entire gene and may have missed non-exonic polymorphisms 
associated with TB disease. Since we did not directly measure host iron indices but 
assessed iron ingestion from vitamin supplements and home-brewed beer, we may have 
misclassified host iron status. Although previous reports indicate that the iron content of 
home-brewed beer is 258 fold higher than that found in commercial beer [15], we did not 
measure the iron content of the beer or systematically account for the frequency of beer 
intake. Finally, we did not test for the possibility of population stratification; however, we 
expect that bias would be minimal due to the homogenous study population with 
common Zulu ancestry.  
 
This candidate gene study was planned as an exploratory pilot study and was not 
powered to account for multiple testing. However, the fact that 5 of 24 SNPS in the 
SLC40A1-associated locus were found to be associated with TB disease in a biologically 
plausible candidate gene suggests that this gene is a good candidate for further study. 
Future studies should sequence the entire SLC40A1 gene to capture the full range of 
polymorphisms, include rigorous measurements of iron status and intake, carefully 
document covariates and be powered to assess potential gene-environment interactions. 
In addition, studies assessing the molecular mechanisms for the associations between 
SLC40A1 polymorphisms and TB disease, including measurement and evaluation of 
SLC40A1 transcripts, would complement the genetic studies and provide further insight 
into the function of FPN1. 
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Table 1. SNPs in SLC40A1 and the association with TB disease 
 
      Risk Allele Frequency 
Position 
GRCh37 
Reference 
SNP ID 
Number (rs) 
Region  TB Case 
SNP/Total 
TB Control 
SNP/Total 
P Value  Odds ratio (95% CI
1) 
 
190452872  rs116496357  Upstream  10/196  14/248  0.80  0.90 (0.39, 2.07) 
190452748  rs6706281  Upstream  82/196  91/246  0.30  1.23 (0.83, 1.80) 
190450880  rs13012833  Upstream  10/196        10/244  0.62  1.26 (0.51,3.09) 
190449526  rs10188680  Upstream  91/194       110/242  0.76  1.06 (0.73,1.55) 
190446541  rs3811621  Upstream  86/194  113/242  0.62  0.91 (0.62,1.33) 
190446284  rs10202029  Upstream  45/194  58/244  0.89  0.97 (0.62,1.51) 
190445284  rs13008848  5’UTR  5/196  0/246  0.01  13.80 (0.76, 251.07)
 2 
190445194  rs1568351  5’UTR  3/196  0/250  0.05  8.92 (0.46, 173.78)
 2 
190444943*    Intron  5/196  1/250  0.05  6.52 (0.76, 56.26) 
190444630  rs1439816  Intron  38/196  54/244  0.48  0.85 (0.53, 1.35) 
190442893  rs1439814  Intron  38/194  71/250  0.03  0.61 (0.39, 0.96) 
190441647  rs3792079  Intron  61/194  83/242  0.53  0.88 (0.59, 1.31) 
190437572  rs11568344  Coding Leu-Leu 
Position 129 
17/196  26/246  0.50  0.80 (0.42, 1.53) 
190432613  rs10188230  Intron  35/192  60/244  0.11  0.68 (0.43,1.09) 
190432172  rs994226  Intron  60/194  60/242  0.15  1.36 (0.89,2.07) 
190430177  rs2304704  Coding Val-Val 
Position 221 
20/196  29/244  0.58  0.84 (0.46,  1.54) 
190430096  rs11568350  Coding Gln-His 
Position 248 
15/196  21/246  0.74  0.89 (0.45, 1.77) 
190428903    Coding Asp-Val 
Position 270 
1/196  1/250  0.86  1.28 (0.08, 20.54) 
190426315  rs61525883  3’UTR  16/194  25/246  0.49  0.79 (0.41, 1.53) 
190425579*    3’UTR  2/168  0/208  0.11  6.19 (0.30, 129.75)
 2 
190425481*    3’UTR  4/196  10/250  0.24  0.5 (0.15, 1.62) 
190424842  rs11884632  Downstream  42/192  56/244  0.79  0.94 (0.60, 1.48) 
190423785  rs2352262  Downstream  56/196  50/246  0.04  1.57 (1.01, 2.43) 
190423678*    Downstream  4/190  2/246  0.25  2.62 (0.48, 14.48) 
 
1. CI = confidence intervals 
2. * =Novel SNPs found through the sequencing procedure 
3. OR and CI estimated using the Haldane odds ratio and confidence intervals as there were 0 SNPs in the 
control population 
4. Codon position 3 
5. Codon position 2 
6. Codon position 2 
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Table 2. SNPs in SLC40A1 with evidence of a gene-environment association 
 
           Risk Allele Frequency 
Position 
GRCh37 
Reference SNP ID 
Number (rs) 
Likelihood 
Ratio Test for 
Interaction 
Case-only 
Test Method 
for Interaction  
TB Case 
SNP/Total 
TB Control  
SNP/Total 
P Value  OR (95% CI) 
 
190452872  rs116496357  0.02  0.06   
      Iron exposure      4/34  1/50  0.06  6.53 (0.70, 61.24) 
      No iron exposure      6/162  13/198  0.23  0.55 (0.20, 1.47) 
190446541  rs3811621  0.004  0.03         
      Iron exposure      12/32  16/48  0.01  3.33 (1.31, 8.48) 
     No iron exposure      66/162     97/194       0.08  0.69 (0.45, 1.05) 
190432613  rs10188230  0.02  0.05         
      Iron exposure      10/32  8/48  0.13  2.27 (0.78, 6.60) 
      No iron exposure      25/160  52/196  0.01  0.51 (0.30, 0.87) 
190423785  rs2352262  0.05  0.10         
      Iron exposure      14/34  9/50  0.02  3.19 (1.18, 8.61) 
      No iron exposure      42/162  41/196  0.26  1.32 (0.81, 2.16) 
 
 
 
 
 
 
 
 
 